DK2148670T3 - Titrering af tapentadol - Google Patents
Titrering af tapentadolInfo
- Publication number
- DK2148670T3 DK2148670T3 DK08749016.5T DK08749016T DK2148670T3 DK 2148670 T3 DK2148670 T3 DK 2148670T3 DK 08749016 T DK08749016 T DK 08749016T DK 2148670 T3 DK2148670 T3 DK 2148670T3
- Authority
- DK
- Denmark
- Prior art keywords
- tapentadol
- titration
- administration
- unitbcontaining
- unitacontaining
- Prior art date
Links
- KWTWDQCKEHXFFR-SMDDNHRTSA-N tapentadol Chemical compound CN(C)C[C@H](C)[C@@H](CC)C1=CC=CC(O)=C1 KWTWDQCKEHXFFR-SMDDNHRTSA-N 0.000 title abstract 4
- 229960005126 tapentadol Drugs 0.000 title abstract 4
- 238000004448 titration Methods 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Adhesive Tapes (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07008218A EP1985292A1 (en) | 2007-04-23 | 2007-04-23 | Titration of tapentadol |
| PCT/EP2008/003178 WO2008128740A1 (en) | 2007-04-23 | 2008-04-21 | Titration of tapentadol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2148670T3 true DK2148670T3 (da) | 2012-03-12 |
Family
ID=38123877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK08749016.5T DK2148670T3 (da) | 2007-04-23 | 2008-04-21 | Titrering af tapentadol |
Country Status (21)
| Country | Link |
|---|---|
| US (4) | US20090012180A1 (enExample) |
| EP (5) | EP1985292A1 (enExample) |
| JP (4) | JP5933176B2 (enExample) |
| KR (3) | KR20100017267A (enExample) |
| CN (1) | CN101730530B (enExample) |
| AT (1) | ATE534378T1 (enExample) |
| AU (1) | AU2008241013B2 (enExample) |
| CA (1) | CA2683786C (enExample) |
| CY (1) | CY1112320T1 (enExample) |
| DK (1) | DK2148670T3 (enExample) |
| ES (1) | ES2378255T3 (enExample) |
| HR (1) | HRP20120147T1 (enExample) |
| IL (1) | IL201479A (enExample) |
| MX (1) | MX2009011444A (enExample) |
| NZ (1) | NZ580415A (enExample) |
| PL (1) | PL2148670T3 (enExample) |
| PT (1) | PT2148670E (enExample) |
| RU (1) | RU2472497C2 (enExample) |
| SI (1) | SI2148670T1 (enExample) |
| WO (1) | WO2008128740A1 (enExample) |
| ZA (1) | ZA200907355B (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1985292A1 (en) * | 2007-04-23 | 2008-10-29 | Grünenthal GmbH | Titration of tapentadol |
| JP6216489B2 (ja) * | 2008-10-30 | 2017-10-18 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 新規の、効力のあるタペンタドール剤形 |
| US8870876B2 (en) * | 2009-02-13 | 2014-10-28 | Tarsus Medical Inc. | Methods and devices for treating hallux valgus |
| US8277459B2 (en) | 2009-09-25 | 2012-10-02 | Tarsus Medical Inc. | Methods and devices for treating a structural bone and joint deformity |
| US8652141B2 (en) | 2010-01-21 | 2014-02-18 | Tarsus Medical Inc. | Methods and devices for treating hallux valgus |
| US20130116333A1 (en) * | 2010-05-05 | 2013-05-09 | Ratiopharm Gmbh | Solid tapentadol in non-crystalline form |
| US8696719B2 (en) | 2010-06-03 | 2014-04-15 | Tarsus Medical Inc. | Methods and devices for treating hallux valgus |
| HRP20161166T1 (hr) * | 2010-06-30 | 2016-11-04 | Grünenthal GmbH | Tapentadol za uporabu u liječenju sindroma iritabilnog crijeva |
| EP3650439B1 (en) * | 2010-07-23 | 2021-02-24 | Grünenthal GmbH | Salts or co-crystals of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol |
| CN101948397A (zh) * | 2010-09-07 | 2011-01-19 | 天津泰普药品科技发展有限公司 | 镇痛药他喷他多重要中间体的制备方法 |
| RS54711B1 (sr) * | 2011-03-04 | 2016-08-31 | Grünenthal GmbH | Parenteralno davanje tapentadola |
| SI3287123T1 (sl) | 2011-03-04 | 2020-07-31 | Gruenenthal Gmbh | Vodna farmacevtska formulacija tapentadola za peroralno uporabo |
| KR101911362B1 (ko) | 2011-03-04 | 2018-10-25 | 그뤼넨탈 게엠베하 | 타펜타돌을 함유하는 반고체 수성 약제학적 조성물 |
| PL2694050T3 (pl) * | 2011-04-05 | 2020-03-31 | Grünenthal GmbH | Tapentadol do stosowania w leczeniu bólu związanego z nerwobólami nerwu trójdzielnego |
| US20120309841A1 (en) * | 2011-04-05 | 2012-12-06 | Gruenenthal Gmbh | Method of Inhibiting Chronification of Pain |
| RS60152B1 (sr) | 2011-04-29 | 2020-05-29 | Gruenenthal Gmbh | Tapentadol za sprečavanje i lečenje depresije i anksioznosti |
| WO2014152296A1 (en) * | 2013-03-15 | 2014-09-25 | Mallinckrodt Llc | Abuse deterrent solid dosage form for immediate release with functional score |
| EP2845625A1 (en) * | 2013-09-04 | 2015-03-11 | Grünenthal GmbH | Tapentadol for use in the treatment of fibromyalgia and chronic fatigue syndrome |
| PT3479823T (pt) | 2015-03-27 | 2020-09-29 | Gruenenthal Gmbh | Formulação estável para administração parentérica de tapentadol |
| JP6853791B2 (ja) * | 2015-05-26 | 2021-03-31 | テクノファージ， インベスティガサン エ デセンボルビメント エム ビオテクノロジア，エスエー | パーキンソン病及び関連する障害の治療における使用のための組成物 |
| WO2017148595A1 (en) * | 2016-02-29 | 2017-09-08 | Grünenthal GmbH | Titration of cebranopadol |
| EP3515412B1 (en) | 2016-09-23 | 2025-04-23 | Grünenthal GmbH | Stable formulation for parenteral administration of tapentadol |
| AU2021237693A1 (en) | 2020-03-16 | 2022-09-08 | Grünenthal GmbH | Scored tablet |
| WO2022194941A1 (en) * | 2021-03-17 | 2022-09-22 | Actelion Pharmaceuticals Ltd | Pharmaceutical dosage system |
| US20240238221A1 (en) * | 2021-05-07 | 2024-07-18 | Grünenthal GmbH | Tapentadol for treating neuropathic pain in covid-19 patients |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4783337A (en) | 1983-05-11 | 1988-11-08 | Alza Corporation | Osmotic system comprising plurality of members for dispensing drug |
| US4612008A (en) * | 1983-05-11 | 1986-09-16 | Alza Corporation | Osmotic device with dual thermodynamic activity |
| US4765989A (en) | 1983-05-11 | 1988-08-23 | Alza Corporation | Osmotic device for administering certain drugs |
| JPS6327805A (ja) | 1986-07-21 | 1988-02-05 | Sumitomo Electric Ind Ltd | 光フアイバの接続用部材及びそれを用いた接続方法 |
| DE4426245A1 (de) * | 1994-07-23 | 1996-02-22 | Gruenenthal Gmbh | 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung |
| US6339105B1 (en) * | 1999-10-12 | 2002-01-15 | Ortho-Mcneil Pharmaceutical, Inc. | Analgesic regimen |
| PE20030527A1 (es) | 2001-10-24 | 2003-07-26 | Gruenenthal Chemie | Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen |
| MXPA05006334A (es) * | 2002-12-13 | 2005-08-26 | Euro Celtique Sa | Dosis de buprenorfina transdermica para analgesia. |
| US7413749B2 (en) * | 2003-03-11 | 2008-08-19 | Purdue Pharma L.P. | Titration dosing regimen for controlled release tramadol |
| DE102007019417A1 (de) | 2007-04-23 | 2008-11-13 | Grünenthal GmbH | Tapentadol zur Schmerzbehandlung bei Arthrose |
| EP1985292A1 (en) * | 2007-04-23 | 2008-10-29 | Grünenthal GmbH | Titration of tapentadol |
-
2007
- 2007-04-23 EP EP07008218A patent/EP1985292A1/en not_active Withdrawn
-
2008
- 2008-04-21 EP EP11008908A patent/EP2422778A1/en not_active Withdrawn
- 2008-04-21 AT AT08749016T patent/ATE534378T1/de active
- 2008-04-21 EP EP08749016A patent/EP2148670B1/en not_active Revoked
- 2008-04-21 RU RU2009142940/15A patent/RU2472497C2/ru active
- 2008-04-21 US US12/106,695 patent/US20090012180A1/en not_active Abandoned
- 2008-04-21 PT PT08749016T patent/PT2148670E/pt unknown
- 2008-04-21 KR KR1020097024357A patent/KR20100017267A/ko not_active Ceased
- 2008-04-21 WO PCT/EP2008/003178 patent/WO2008128740A1/en not_active Ceased
- 2008-04-21 MX MX2009011444A patent/MX2009011444A/es active IP Right Grant
- 2008-04-21 DK DK08749016.5T patent/DK2148670T3/da active
- 2008-04-21 PL PL08749016T patent/PL2148670T3/pl unknown
- 2008-04-21 CN CN200880021172XA patent/CN101730530B/zh not_active Expired - Fee Related
- 2008-04-21 HR HR20120147T patent/HRP20120147T1/hr unknown
- 2008-04-21 AU AU2008241013A patent/AU2008241013B2/en active Active
- 2008-04-21 EP EP19189638.0A patent/EP3603630A1/en not_active Withdrawn
- 2008-04-21 EP EP16192734.8A patent/EP3143993A1/en not_active Withdrawn
- 2008-04-21 NZ NZ580415A patent/NZ580415A/en not_active IP Right Cessation
- 2008-04-21 KR KR1020177037810A patent/KR102078999B1/ko active Active
- 2008-04-21 CA CA2683786A patent/CA2683786C/en active Active
- 2008-04-21 JP JP2010504517A patent/JP5933176B2/ja active Active
- 2008-04-21 SI SI200830540T patent/SI2148670T1/sl unknown
- 2008-04-21 KR KR20157003922A patent/KR20150027840A/ko not_active Ceased
- 2008-04-21 ES ES08749016T patent/ES2378255T3/es active Active
-
2009
- 2009-10-13 IL IL201479A patent/IL201479A/en active IP Right Grant
- 2009-10-20 ZA ZA200907355A patent/ZA200907355B/xx unknown
-
2012
- 2012-02-06 CY CY20121100123T patent/CY1112320T1/el unknown
-
2015
- 2015-11-18 US US14/945,289 patent/US20160074342A1/en not_active Abandoned
-
2016
- 2016-01-21 JP JP2016009738A patent/JP2016128468A/ja active Pending
- 2016-12-05 US US15/369,257 patent/US20170079938A1/en not_active Abandoned
-
2017
- 2017-09-28 JP JP2017187306A patent/JP2018030864A/ja active Pending
-
2019
- 2019-04-10 JP JP2019074538A patent/JP2019131598A/ja active Pending
- 2019-06-12 US US16/439,135 patent/US11344512B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2148670T3 (da) | Titrering af tapentadol | |
| CY1122687T1 (el) | Συνθεσεις και μεθοδοι για την τροποποιηση της smn2 συναρμογης σε ενα υποκειμενο | |
| EA201001402A1 (ru) | Фармацевтические растворы, способ получения и терапевтическое применение | |
| CY1115455T1 (el) | Χρησιμοποιηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια του πονου νευροπαθειας | |
| EA201300242A1 (ru) | Фармацевтические композиции, содержащие замещенные ациланилиды | |
| MX2014004862A (es) | Formulaciones de polimero acrilico. | |
| CY1112067T1 (el) | Χρηση φλιμπανσερινης για την θεραπεια διαταραχων προ-εμμηνοπαυσιακης σεξουαλικης επιθυμιας | |
| AR061446A1 (es) | Utilizacion de la 1,7 -dimetilxantina para la fabricacion de un medicamento psicoanaleptico no ansiogeno destinado al tratamiento de un trastorno neuropsiquiatrico | |
| CY1118813T1 (el) | Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων | |
| BRPI0907036A2 (pt) | Conjunto de máscara para fornecer gás para um paciente, e, kit de conjunto de máscara para fornecer um gás para um paciente. | |
| NO20084368L (no) | Stabile emulsjonsformuleringer | |
| BRPI0815577A2 (pt) | Peptídeo foxm1 e agente medicinal compreendendo o mesmo. | |
| EA200801997A1 (ru) | Новые соединения | |
| CY1115975T1 (el) | Ταπενταδολη για τη θεραπεια πονου σε αρθριτιδα | |
| EA201100255A1 (ru) | 5-алкинилпиримидины | |
| MY143269A (en) | Use of agomelatine in obtaining medicaments intended for the treatment of generalized anxiety disorder | |
| EA201171043A1 (ru) | Композиции и способы длительной терапии с применением аминопиридинов | |
| CR20110552A (es) | Tratamiento de transtornos resistentes a la insulina | |
| BR112012007888A2 (pt) | "métodos de tratamento usando anticorpos anti-ldl oxidada". | |
| CY1114760T1 (el) | Θεραπευτικη αγωγη αθηροσκληρωσης | |
| CL2015001180A1 (es) | Combinacion farmaceutica que comprende un copolimero de carboximetilcelulosa sodica con un grado de sustitucion de 0,35 a 0,80 y gosipol o un medicamento para el tratamiento de trastornos cognitivos seleccionado de neurolepticos, antidepresivos, anticonvulsivos o una combinacion de los mismos. | |
| EA200970816A1 (ru) | Новая лекарственная форма | |
| EA200702336A1 (ru) | ПРИМЕНЕНИЕ 24-норУДХК | |
| EA200970970A1 (ru) | Применение 4-циклопропилметокси-n-(3,5-дихлор-1-оксидо-4-пиридин-4-ил)-5-(метокси)пиридин-2-карбоксамида для лечения моторных нарушений, связанных с болезнью паркинсона | |
| EA200901387A1 (ru) | Фармацевтическая композиция, включающая дезлоратадин |